Advertisement
Organisation › Details
Human Longevity (Group)
Human Longevity, Inc. (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. HLI’s business areas include the HLI Health Nucleus, a genomic powered clinical research center which uses whole genome sequence analysis, advanced clinical imaging and innovative machine learning, along with curated personal health information, to deliver the most complete picture of individual health; HLIQ™ Whole Genome and HLIQ Oncology. *
Start | 2013-01-01 established | |
Industry | DNA/RNA sequencing | |
Industry 2 | stem cell therapy | |
Person | Collins, Cynthia (Cindy) (Editas Medicine 201908–202102 before Human Longevity + GE Healthcare + Clarient Dx LEFT 2/21) | |
Person 2 | Venter, J. Craig | |
Region | San Diego, CA | |
Country | United States (USA) | |
Street | 4570 Executive Drive | |
City | 92121 San Diego, CA | |
Tel | +1-858-249-7500 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Human Longevity, Inc.. (6/15/17). "Press Release: Human Longevity, Inc. Announces Agreement with Merck KGaA, Darmstadt, Germany to Engage in Cancer Biomarker Discovery in Advanced Melanoma". San Diego, CA. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for Human Longevity (Group)
- [1] Editas Medicine, Inc.. (8/6/19). "Press Release: Editas Medicine Appoints Cynthia Collins as President and Chief Executive Officer". Cambridge, MA....
- [2] Editas Medicine, Inc.. (1/22/19). "Press Release: Editas Medicine Announces Chief Executive Officer Transition. Katrine Bosley to Step Down as President and CEO". Cambridge, MA....
- [3] Editas Medicine, Inc.. (12/10/18). "Press Release: Editas Medicine Names Cynthia Collins to Board of Directors". Cambridge, MA....
- [4] Human Longevity, Inc.. (6/15/17). "Press Release: Human Longevity, Inc. Announces Agreement with Merck KGaA, Darmstadt, Germany to Engage in Cancer Biomarker Discovery in Advanced Melanoma". San Diego, CA....
- [5] Illumina, Inc.. (1/9/17). "Press Release: Illumina Introduces the NovaSeq Series—a New Architecture Designed to Usher in the $100 Genome". San Diego, CA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top